Literature DB >> 6210089

Adenosine inhibits and potentiates IgE-dependent histamine release from human lung mast cells by an A2-purinoceptor mediated mechanism.

P J Hughes, S T Holgate, M K Church.   

Abstract

Adenosine, at physiological concentrations, may modulate histamine release from mechanically dispersed human lung mast cells. Addition of adenosine to the dispersed mast cells at times up to 5 min before immunological challenge with anti-human IgE inhibited histamine release. When added after this time adenosine caused a small potentiation of immunological histamine release, maximum potentiation occurring with addition of adenosine 5 min after challenge, coincidental with the end of the rapid phase of histamine release. Both inhibition and potentiation of histamine release were more pronounced with low levels of immunological challenge. Theophylline, 8-phenyltheophylline, dipyridamole and analogues of adenosine were used to determine the site of action of adenosine on mast cell mediator release. Theophylline and 8-phenyltheophylline displaced the concentration-response lines for both inhibition and potentiation of mediator release by adenosine to the right whilst dipyridamole, 1 microM, was without significant effect. This suggests that both effects result from interaction of adenosine with cell surface receptors. This was confirmed by demonstrating that the P-site agonist 2',5'-dideoxyadenosine produced only inhibition of histamine release, an effect which was inhibited by dipyridamole but not by theophylline. The rank potency order of adenosine analogues, NECA much greater than adenosine greater than or equal to L-PIA greater than or equal to D-PIA in both inhibiting and potentiating immunological histamine release suggests that both effects are mediated through activation of cell surface A2-purinoceptors. Since adenosine is released into the circulation of asthmatic subjects following bronchial provocation with antigen, causes bronchoconstriction and has the ability to modulate mast cell histamine release, this nucleoside should be considered as an additional inflammatory mediator of allergic reactions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6210089     DOI: 10.1016/0006-2952(84)90050-9

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  39 in total

1.  Characterization of adenosine receptors involved in adenosine-induced bronchoconstriction in allergic rabbits.

Authors:  A el-Hashim; B D'Agostino; M G Matera; C Page
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

Review 2.  Adenosine bronchoconstriction in asthma: investigations into its possible mechanism of action.

Authors:  W H Ng; R Polosa; M K Church
Journal:  Br J Clin Pharmacol       Date:  1990       Impact factor: 4.335

Review 3.  G protein-coupled receptors and the modification of FcepsilonRI-mediated mast cell activation.

Authors:  Hye Sun Kuehn; Alasdair M Gilfillan
Journal:  Immunol Lett       Date:  2007-09-18       Impact factor: 3.685

Review 4.  Adenosine receptors and asthma.

Authors:  R A Brown; D Spina; C P Page
Journal:  Br J Pharmacol       Date:  2008-03       Impact factor: 8.739

Review 5.  Adenosine signaling and the regulation of chronic lung disease.

Authors:  Yang Zhou; Daniel J Schneider; Michael R Blackburn
Journal:  Pharmacol Ther       Date:  2009-05-05       Impact factor: 12.310

6.  Intracellular adenosine inhibits IgE-dependent degranulation of human skin mast cells.

Authors:  Gregorio Gomez; Vincent Nardone; Sahar Lotfi-Emran; Wei Zhao; Lawrence B Schwartz
Journal:  J Clin Immunol       Date:  2013-11       Impact factor: 8.317

Review 7.  Pharmacological studies of pulmonary anaphylaxis in vitro: a review.

Authors:  P O Ogunbiyi; P Eyre
Journal:  Agents Actions       Date:  1985-12

Review 8.  Adenosine bronchoprovocation: a promising marker of allergic inflammation in asthma?

Authors:  R Polosa; S T Holgate
Journal:  Thorax       Date:  1997-10       Impact factor: 9.139

9.  Protective effects of calcitonin gene-related peptide-mediated evodiamine on guinea-pig cardiac anaphylaxis.

Authors:  Wei-Qing Rang; Yan-Hua Du; Chang-Ping Hu; Feng Ye; Gui-Shan Tan; Han-Wu Deng; Yuan-Jian Li
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-02-04       Impact factor: 3.000

10.  Adenosine closes the K+ channel KCa3.1 in human lung mast cells and inhibits their migration via the adenosine A2A receptor.

Authors:  S Mark Duffy; Glenn Cruse; Christopher E Brightling; Peter Bradding
Journal:  Eur J Immunol       Date:  2007-06       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.